Literature DB >> 29488137

Alterations in System xc- Expression in the Retina of Type 1 Diabetic Rats and the Role of Nrf2.

Raul Carpi-Santos1, Karin C Calaza2.   

Abstract

Nrf2 (nuclear factor erythroid 2-related factor 2), a transcription factor that controls expression of several proteins that are related to cellular antioxidant capacity, such as the subunit xCT of the system xc-, is dysregulated in diabetes. Recently, it was described that system xc- is decreased in the retina after 3 weeks of diabetes. So, in the present work, the temporal relationship between xCT and Nrf2 in the retina of diabetic animals was investigated. Diabetes was induced in male Wistar rats (200 g) by a single injection of streptozotocin, and retinas were collected after 1, 2, and 6 months of diabetes induction. Expression of xCT, Nrf2 activity, and binding to antioxidant-responsive element (ARE) sequence were evaluated. Glutathione and reactive oxygen species (ROS) levels were also assessed. After 1 month of diabetes, Nrf2 activity, xCT expression, and glutathione levels were reduced whereas ROS were increased. Although glutathione and ROS levels remain unchanged until later stages, Nrf2 activity and xCT expression returned to normal levels after 2 months. However, they were decreased again at 6 months of diabetes. Accordingly, Nrf2 binding to xCT ARE sequence followed the same pattern of Nrf2 activity and xCT expression. These data showed that retinal xCT expression is regulated by Nrf2 in diabetic condition. The results also demonstrated a temporal relationship between Nrf2 and system xc- which could be implicated in the initiation of oxidative stress in retina in diabetes.

Entities:  

Keywords:  Diabetes; Glutathione; Nrf2; Retina; xCT

Mesh:

Substances:

Year:  2018        PMID: 29488137     DOI: 10.1007/s12035-018-0961-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  53 in total

1.  Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress.

Authors:  Renu A Kowluru; Vibhuti Kowluru; Ye Xiong; Ye-Shih Ho
Journal:  Free Radic Biol Med       Date:  2006-02-06       Impact factor: 7.376

2.  Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization.

Authors:  Yumiko Kawai; Lakisha Garduño; Melanie Theodore; Jianqi Yang; Ifeanyi J Arinze
Journal:  J Biol Chem       Date:  2010-12-31       Impact factor: 5.157

3.  The role of vascular endothelial growth factor, tumor necrosis factor alpha and interleukin-6 in pathogenesis of diabetic retinopathy.

Authors:  Małgorzata Myśliwiec; Anna Balcerska; Katarzyna Zorena; Jolanta Myśliwska; Paweł Lipowski; Krystyna Raczyńska
Journal:  Diabetes Res Clin Pract       Date:  2007-08-22       Impact factor: 5.602

4.  Exchange of cystine and glutamate across plasma membrane of human fibroblasts.

Authors:  S Bannai
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

5.  TIAM1-RAC1 signalling axis-mediated activation of NADPH oxidase-2 initiates mitochondrial damage in the development of diabetic retinopathy.

Authors:  Renu A Kowluru; Anjaneyulu Kowluru; Rajakrishnan Veluthakal; Ghulam Mohammad; Ismail Syed; Julia M Santos; Manish Mishra
Journal:  Diabetologia       Date:  2014-02-20       Impact factor: 10.122

6.  GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress.

Authors:  Ana I Rojo; María Rosa de Sagarra; Antonio Cuadrado
Journal:  J Neurochem       Date:  2007-11-13       Impact factor: 5.372

7.  Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.

Authors:  Mamta Kanwar; Pooi-See Chan; Timothy S Kern; Renu A Kowluru
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

Review 8.  Regulation of glutathione synthesis.

Authors:  Shelly C Lu
Journal:  Mol Aspects Med       Date:  2008-06-14

9.  Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo.

Authors:  Yi Tan; Tomonaga Ichikawa; Jinqing Li; Qiusheng Si; Huaitao Yang; Xiangbai Chen; Curtis S Goldblatt; Colin J Meyer; Xiaokun Li; Lu Cai; Taixing Cui
Journal:  Diabetes       Date:  2011-02       Impact factor: 9.461

10.  Betaine inhibits vascularization via suppression of Akt in the retinas of streptozotocin-induced hyperglycemic rats.

Authors:  Young-Giun Kim; Hyung-Ho Lim; Suh-Ha Lee; Mal-Soon Shin; Chang-Ju Kim; Hyeon Jeong Yang
Journal:  Mol Med Rep       Date:  2015-04-15       Impact factor: 2.952

View more
  11 in total

1.  Artemether attenuates renal tubular injury by regulating iron metabolism in mice with streptozotocin-induced diabetes.

Authors:  Guangli Rong; Yuchun Cai; Wenci Weng; Yijun Chen; Xuewen Yu; Mumin Shao; Pengxun Han; Huili Sun
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 2.  Mechanisms of Ferroptosis and Emerging Links to the Pathology of Neurodegenerative Diseases.

Authors:  Yiyan Sun; Xiaohuan Xia; Diksha Basnet; Jialin C Zheng; Jian Huang; Jianhui Liu
Journal:  Front Aging Neurosci       Date:  2022-06-28       Impact factor: 5.702

3.  SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.

Authors:  Lei Feng; Kaikai Zhao; Liangchao Sun; Xiaoyang Yin; Junpeng Zhang; Conghe Liu; Baosheng Li
Journal:  J Transl Med       Date:  2021-08-26       Impact factor: 5.531

Review 4.  Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?

Authors:  Jia-Yue Duan; Xiao Lin; Feng Xu; Su-Kang Shan; Bei Guo; Fu-Xing-Zi Li; Yi Wang; Ming-Hui Zheng; Qiu-Shuang Xu; Li-Min Lei; Wen-Lu Ou-Yang; Yun-Yun Wu; Ke-Xin Tang; Ling-Qing Yuan
Journal:  Front Cell Dev Biol       Date:  2021-07-09

5.  Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.

Authors:  Inês Santos; Cristiano Ramos; Cindy Mendes; Catarina O Sequeira; Catarina S Tomé; Dalila G H Fernandes; Pedro Mota; Rita F Pires; Donato Urso; Ana Hipólito; Alexandra M M Antunes; João B Vicente; Sofia A Pereira; Vasco D B Bonifácio; Sofia C Nunes; Jacinta Serpa
Journal:  Nutrients       Date:  2019-10-19       Impact factor: 5.717

Review 6.  Ferroptosis Signaling and Regulators in Atherosclerosis.

Authors:  Yuqin Wang; Yajie Zhao; Ting Ye; Liming Yang; Yanna Shen; Hong Li
Journal:  Front Cell Dev Biol       Date:  2021-12-16

7.  High glucose concentrations induce oxidative stress by inhibiting Nrf2 expression in rat Müller retinal cells in vitro.

Authors:  Jesús Silvestre Albert-Garay; Juan Rafael Riesgo-Escovar; Rocío Salceda
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

Review 8.  Ferroptosis and Its Potential Role in the Nervous System Diseases.

Authors:  Yiyang Zhou; Wei Lin; Tian Rao; Jinyu Zheng; Tianlei Zhang; Min Zhang; Zhenlang Lin
Journal:  J Inflamm Res       Date:  2022-03-03

Review 9.  Identification, Expression, and Roles of the Cystine/Glutamate Antiporter in Ocular Tissues.

Authors:  Renita M Martis; Luis J Knight; Paul J Donaldson; Julie C Lim
Journal:  Oxid Med Cell Longev       Date:  2020-06-18       Impact factor: 6.543

10.  Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1/Nrf2 Signaling Pathway Activation.

Authors:  Danlei Li; Xiaoman Liu; Wenhu Pi; Yang Zhang; Lei Yu; Cheng Xu; Zhenzhu Sun; Jianjun Jiang
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.